methamphetamine has been researched along with Developmental Psychomotor Disorders in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ares-Santos, S; Granado, N; Moratalla, R; Tizabi, Y | 1 |
| Foltin, RW; Gunderson, EW; Hart, CL; Johanson, CE; Kirkpatrick, MG; Levin, FR | 1 |
| Curran, HV; Freeman, TP; Hussain, N; Karimi, K; Morgan, CJ; Vaughn-Jones, J | 1 |
| Caprioli, A; Coccurello, R; Ghirardi, O; Virmani, A | 1 |
| Chang, L; Ding, YS; Fowler, JS; Franceschi, D; Gatley, SJ; Hitzemann, R; Leonido-Yee, M; Logan, J; Miller, EN; Sedler, MJ; Volkow, ND; Wang, GJ; Wong, C | 1 |
| Karczmar, AG; Richardson, D; Scudder, CL | 1 |
1 trial(s) available for methamphetamine and Developmental Psychomotor Disorders
| Article | Year |
|---|---|
Comparison of intranasal methamphetamine and d-amphetamine self-administration by humans.
Topics: Administration, Intranasal; Adult; Ambulatory Care; Amphetamine-Related Disorders; Cardiovascular Diseases; Central Nervous System Stimulants; Cross-Over Studies; Dextroamphetamine; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Male; Methamphetamine; New York; Psychomotor Disorders; Self Administration | 2012 |
5 other study(ies) available for methamphetamine and Developmental Psychomotor Disorders
| Article | Year |
|---|---|
Striatal Reinnervation Process after Acute Methamphetamine-Induced Dopaminergic Degeneration in Mice.
Topics: Animals; Calcium-Binding Proteins; Central Nervous System Stimulants; Corpus Striatum; Disease Models, Animal; Dopamine; GAP-43 Protein; Glial Fibrillary Acidic Protein; Locomotion; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Microfilament Proteins; Neurodegenerative Diseases; Presynaptic Terminals; Psychomotor Disorders; Recovery of Function; Silver Staining; Time Factors; Tyrosine 3-Monooxygenase | 2018 |
Cognitive and subjective effects of mephedrone and factors influencing use of a 'new legal high'.
Topics: Case-Control Studies; Central Nervous System Stimulants; Executive Function; Female; Humans; Male; Memory Disorders; Methamphetamine; Psychomotor Disorders; Speech Disorders; Substance-Related Disorders; Young Adult | 2012 |
Valproate and acetyl-L-carnitine prevent methamphetamine-induced behavioral sensitization in mice.
Topics: Acetylcarnitine; Analysis of Variance; Animals; Behavior, Animal; Drug Administration Schedule; Drug Interactions; Male; Methamphetamine; Mice; Motor Activity; Neuroprotective Agents; Psychomotor Disorders; Time Factors; Valproic Acid | 2007 |
Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers.
Topics: Adult; Brain; Brain Chemistry; Carbon Radioisotopes; Carrier Proteins; Caudate Nucleus; Cerebellum; Dopamine; Dopamine Plasma Membrane Transport Proteins; Female; Humans; Male; Membrane Glycoproteins; Membrane Transport Proteins; Methamphetamine; Methylphenidate; Nerve Tissue Proteins; Neuropsychological Tests; Psychomotor Disorders; Putamen; Substance-Related Disorders; Tomography, Emission-Computed; Verbal Learning | 2001 |
Intergeneric behavioral differences among methamphetamine treated mice.
Topics: Aggression; Animals; Behavior, Animal; Drug Tolerance; Exploratory Behavior; Feeding Behavior; Female; Genetics, Behavioral; Grooming; Humans; Male; Methamphetamine; Mice; Mice, Inbred Strains; Psychomotor Disorders; Sexual Behavior, Animal; Sleep | 1972 |